by Uniseed01 | Sep 29, 2020 | Latest News
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study • New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced • Novel therapy developed by...
by Uniseed01 | Sep 1, 2020 | Latest News
A four-part article on Uniseed’s journey over the past 20 years. Each week in September, we will post a chapter covering the subsequent 5 years in Uniseed’s journey. Part 1 – 2000 – 2005 Part 2 – 2006 – 2010 Part 3 – 2011 – 2015...
by Uniseed01 | Aug 31, 2020 | Latest News
Uniseed CEO Peter Devine talks with Global University Venturing’s Thierry Heles about Uniseed’s journey over the past 20 years. CLICK below to tune in.
by Uniseed01 | Aug 3, 2020 | Latest News
FDA Approves Xeglyze™ for the topical treatment of head lice infestation Xeglyze New Drug Application Approved by the US FDA, Culmination of a 20-year journey for Hatchtech from drug discovery to approval, Hatchtech joins small but growing list of...
by Uniseed01 | Jul 20, 2020 | Latest News
Nanotech company Ferronova secures BioMedTech Horizons Grant Uniseed investee Ferronova Pty Ltd has been awarded an $826,000 grant from the Australian Government’s BioMedTech Horizons (BTMH) program, operated by MTPConnect to further its nanoparticle development...
by Uniseed01 | Jun 17, 2020 | Latest News
Uniseed and BioCurate sign early stage research commercialisation agreement Melbourne, 17 June, 2020 – BioCurate, an independently-operated joint venture between the University of Melbourne and Monash University, has entered into an agreement with leading Australian...
Recent Comments